Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Allurion Technologies, Inc. (ALUR : NYSE)
 
 • Company Description   
Allurion Technologies Inc. is dedicated to ending obesity. The Allurion Program is a weight loss platform which combines the Allurion Gastric Balloon and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. Allurion Technologies Inc., formerly known as Compute Health Acquisition Corp., is based in NATICK, Mass.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.99 Daily Weekly Monthly
20 Day Moving Average: 179,587 shares
Shares Outstanding: 7.46 (millions)
Market Capitalization: $22.30 (millions)
Beta: -0.47
52 Week High: $26.75
52 Week Low: $2.15
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 16.80% 12.42%
12 Week 27.78% 7.48%
Year To Date -72.19% -73.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11 HURON DRIVE
-
NATICK,MA 01760
USA		 ph: 508-647-4000
fax: -		 investors@allurion.com http://www.allurion.com
 
 • General Corporate Information   
Officers
Shantanu Gaur - Chief Executive Officer
Omar Ishrak - Chairman
Ojas Buch - Chief Operating Officer
Keith Johns - Director
Nicholas Lewin - Director

Peer Information
Allurion Technologies, Inc. (BJCT)
Allurion Technologies, Inc. (CADMQ)
Allurion Technologies, Inc. (APNO)
Allurion Technologies, Inc. (UPDC)
Allurion Technologies, Inc. (IMTIQ)
Allurion Technologies, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 02008G201
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
Share - Related Items
Shares Outstanding: 7.46
Most Recent Split Date: 1.00 (0.04:1)
Beta: -0.47
Market Capitalization: $22.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.54 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.21 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.79
EPS Growth
vs. Year Ago Period: -84.36%
vs. Previous Quarter: 106.14%
Sales Growth
vs. Year Ago Period: -40.55%
vs. Previous Quarter: -0.20%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -41.49
12/31/24 - -43.48
Current Ratio
06/30/25 - -
03/31/25 - 2.09
12/31/24 - 1.44
Quick Ratio
06/30/25 - -
03/31/25 - 1.88
12/31/24 - 1.26
Operating Margin
06/30/25 - -
03/31/25 - -61.74
12/31/24 - -64.33
Net Margin
06/30/25 - -
03/31/25 - -86.05
12/31/24 - -81.44
Pre-Tax Margin
06/30/25 - -
03/31/25 - -83.44
12/31/24 - -79.20
Book Value
06/30/25 - -
03/31/25 - -9.36
12/31/24 - -30.08
Inventory Turnover
06/30/25 - -
03/31/25 - 2.36
12/31/24 - 2.31
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©